Type 2 diabetes (T2D) is one of the most prevalent chronic condition in older people, a heterogeneous population in terms of health status. Consequently, risks and benefits of glycaemic control by glucose-lowering treatment may differ considerably between patients and must be wisely balanced to avoid harmful consequences, i.e. hypoglycaemic events. This can be achieved by individualising treatment goals according to patient’s characteristics. This thesis (i) reviewed recommendations from recent Clinical Practice Guidelines for individualised glycaemic management in older people with T2D, (ii) assessed the application of these recommendations in clinical practice, and (iii) described the metabolic heterogeneity in older people with T2D. The results provide strong encouragement to follow more assiduously recommendations for individualising the glycaemic management in older patients with T2D, and to continue research in this field to provide high-level evidence recommendations.
Affiliations
UCLouvainSSS/LDRI - Louvain Drug Research Institute
UCLouvainSSS/IRSS - Institut de recherche santé et société
Citations
APA
Chicago
FWB
Christiaens, A. (2022). Implications of health and metabolic heterogeneities for glycaemic management in older patients with type 2 diabetes. https://hdl.handle.net/2078.5/110590